Social Media and Networks in Pharmacovigilance I. Ralph EdwardsMarie Lindquist Editorial 21 November 2012 Pages: 267 - 271
Today’s Challenges in Pharmacovigilance Hans C. EbbersAukje K. Mantel-TeeuwisseHubert G. Leufkens Review Article 21 November 2012 Pages: 273 - 287
The Role of Computerized Decision Support in Reducing Errors in Selecting Medicines for Prescription Melissa T. BaysariJohanna WestbrookRichard O. Day Review Article 21 November 2012 Pages: 289 - 298
Individual Case Safety Reports —How to Determine the Onset Date of an Adverse Reaction Michael J. KlepperBrian Edwards Short Communication 21 November 2012 Pages: 299 - 305
Dose Variations Associated with Formulations of NSAID Prescriptions for Children Kristina StarOla CasterI. Ralph Edwards Short Communication 21 November 2012 Pages: 307 - 317
Patient Experiences of Serious Adverse Drug Reactions and Their Attitudes to Medicines Tehreem F. ButtAnthony R. CoxRobin E. Ferner Original Research Article 21 November 2012 Pages: 319 - 328
The Impact in Japan of Regulatory Action on Prescribing of Dopamine Receptor Agonists Nobuhiro OobaTakuhiro YamaguchiKiyoshi Kubota Original Research Article 21 November 2012 Pages: 329 - 338
Safety of Herbal Products in Thailand Surasak SaokaewWimon SuwankesawongNathorn Chaiyakunapruk Original Research Article 21 November 2012 Pages: 339 - 350
Using Facebook to Increase Spontaneous Reporting of Adverse Drug Reactions Marinela Z. KnezevicIvana C. BivolarevicSlobodan M. Jankovic Correspondence 21 November 2012 Pages: 351 - 352
Attributing Hyponatraemia to Treatment with Antipsychotic Medications Richard C. JosiassenRita A. ShaughnessyBrett Audino Correspondence 21 November 2012 Pages: 353 - 354
The Authors’ Reply Didier MeulendijksCyndie K. MannesseToine C.G. Egberts Correspondence 21 November 2012 Pages: 354 - 355